Investigating Cytokine Genes of Stem Cell Donors
NCT00353821 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24
Last updated 2019-12-12
Summary
This study seeks to investigate the factors that may account for the differences in the way a stem cell recipient s immune system works after a transplant. It will focus on cytokine genes, which give specific instructions to the genes and which may influence immune system response. More specifically, the purpose of the study is to find out how gene polymorphisms (gene variations among the population) affect the success or failure of a stem cell transplant.
Study participants will have donated blood for a stem cell transplant. They will be asked to give consent for NIH personnel to run special tests on these blood samples, which will have been placed in storage. It is hoped that blood samples will be studied from 600 stem cell donors.
Conditions
- Stem Cell Transplantation
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
A. John Barrett, M.D. · National Heart, Lung, and Blood Institute (NHLBI)
Eligibility
- Min Age
- 2 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-06-05
- Completion
- 2018-03-02
Countries
- United States
Study Locations
More Related Trials
-
Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs
NCT00319657 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
NCT01206309 ·Status: COMPLETED
-
Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies
NCT00079391 ·Status: COMPLETED ·Phase: PHASE2
-
Markers of Inflammation in Hematopoietic Stem Cell Transplant
NCT00579397 ·Status: COMPLETED
-
Cytokine Gene Polymorphisms in Bone Marrow Failure
NCT00085670 ·Status: COMPLETED
-
Evaluation of Toxicity From Stem Cell Transplant
NCT00631787 ·Status: COMPLETED
-
Study of the Complications Associated With Certain Stem Cell Transplants
NCT01919099 ·Status: COMPLETED
-
Screening for Subjects to Participate in Studies of Blood Disorders
NCT00695123 ·Status: COMPLETED
-
Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell Transplant
NCT03511794 ·Status: COMPLETED
-
Studies of the Immune Response to Vaccination After Hematopoietic Stem Cell Transplantation
NCT01581164 ·Status: COMPLETED
-
Metagenomics Next-generation Sequencing Approach to Detect Microbial DNA/RNA Overtime in Individuals Undergoing Hematopoietic Stem Cell Transplant
NCT06904053 ·Status: RECRUITING
-
Quality of Life in Patients Who Have Undergone Stem Cell Transplant
NCT00128960 ·Status: COMPLETED
-
Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients
NCT01135355 ·Status: TERMINATED
-
Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation
NCT06093867 ·Status: RECRUITING
-
The Role of CK18F in Predicting Graft-Versus-Host Disease (GvHD)
NCT00935324 ·Status: UNKNOWN
-
Pipeline Integrating Gut Metagenome Data, Host Immunogenetic Characteristics and Clinical Gut Inflammatory Biomarkers
NCT02940093 ·Status: UNKNOWN
-
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
NCT01890486 ·Status: RECRUITING
-
Cardiomyopathy Following Stem Cell Transplantation
NCT00352209 ·Status: COMPLETED
-
Biomarkers in Transplant Recipients to Improve Outcomes
NCT01163578 ·Status: RECRUITING
-
Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010
NCT03111745 ·Status: COMPLETED
-
Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT
NCT02398708 ·Status: COMPLETED
-
Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study
NCT02255123 ·Status: COMPLETED
-
Induction of Donor Specific Tolerance in Recipients of Cardiac Allografts by Donor Stem Cell Infusion
NCT00497757 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes
NCT03532971 ·Status: COMPLETED
-
Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant
NCT05722210 ·Status: NOT_YET_RECRUITING